Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccine, Trastuzumab, and Cyclophosphamide in HER2+ Breast Cancer
NCT00847171Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Dec 2008
- Primary completion
- Jun 2013
- Modality
- Gene Editing, Prophylactic Vaccines, Gene Silencing
- Countries
- 1
01
Overview
A Phase 2 trial of SV-BR-1-GM in breast cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Dec 2008; status: completed.
02
Drugs
SV-BR-1-GM
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00847171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847171.